Post-authorization clinical studies

X7 Research offers a wide range of services in the post-marketing phase of the drug lifecycle. We are ready to conduct both large-scale studies to obtain big amounts of real-world data (RWD) and small-scale exploratory studies. The X7 Research team is ready for any challenge and the most ambitious projects.

The X7 Research team has extensive experience in post-marketing clinical studies in Russia, EAEU, CIS, EU. We work by the most actual legislative requirements in the field of drug circulation.